Quantcast

Latest pharmaceutical industry Stories

2014-06-11 12:29:22

WASHINGTON, June 11, 2014 /PRNewswire/ -- mProve Health's Trial Guide app takes off across numerous studies and is localized for more than 30 countries. As smartphone penetration tops 65% in many developed countries, more and more Sponsors are seeing the benefit of offering a customized Study App to their patients, not only in the US, but internationally. After all, most people have their phone within an arm's length 19 hours a day, and smartphone users often look at their phones more...

2014-06-11 12:29:06

PITTSBURGH, June 11, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has launched Risedronate Sodium Tablets USP, 150 mg, the generic version of Warner Chilcott's Actonel(®) Tablets. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for the treatment and prevention of osteoporosis in postmenopausal women. Risedronate Sodium Tablets USP, 150 mg, had...

2014-06-11 08:30:55

ROCKLAND, Mass., June 11, 2014 /PRNewswire/ -- EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany announced today its commitment to U.S. military veterans and their spouses with the introduction of the Compassionate Corps Program. Through the program, veterans and their spouses may be eligible to receive free fertility medicine. To view the multimedia assets associated with this release, please click:...

2014-06-11 08:30:11

James Sergi brings extensive experience to LifeSciences, which provides innovative solutions for reducing time to market, developments costs, and resources of new drugs and devices. GLEN BURNIE, Md., June 11, 2014 /PRNewswire/ -- CSSi, the leader in patient recruitment solutions for the clinical research industry, recently announced the formation of the company's LifeSciences division. This entity was created to complement our other service offerings by providing guidance and...

2014-06-11 08:29:31

SOUTH PLAINFIELD, N.J., June 11, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the appointment of Ronald C. Renaud, Jr. to the company's Board of Directors. Mr. Renaud has served as the President and Chief Executive Officer of Idenix Pharmaceuticals, Inc., a public biopharmaceutical company, since October 2010. http://photos.prnewswire.com/prnvar/20010919/PTCLOGO "We are delighted to welcome Ron to PTC's Board of Directors. Ron brings tremendous skills...

2014-06-11 08:28:42

SAN FRANCISCO, June 11, 2014 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR), a biopharmaceutical company developing novel pain and cancer therapeutics, today announced that NASDAQ has halted trading of the company's common stock. The U.S. Food and Drug Administration's (FDA) Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) is meeting on June 11-12, 2014 to discuss potential cardiovascular risk associated with peripherally-acting opioid receptor antagonists which...

2014-06-11 04:22:05

CAMBRIDGE, Massachusetts and LONDON, June 11, 2014 /PRNewswire/ -- Establishes New Business to Help International Companies Hire Their First Employees in the United States Life sciences consulting firm Alacrita [http://www.alacritaconsulting.com ] announced today that it has launched "Foothold America [http://www.footholdamerica.com ]", a new business which enables non-US life science companies to easily hire their first employees in the United States. The US is the...

2014-06-10 23:13:15

The Long Island, New York law firm of Rudolph F. X. Migliore, P. C. has announced the makers of the drug called Pradaxa have agreed to pay out 650 million to resolve most of the 4,000 cases filed in state and federal courts. (PRWEB) June 10, 2014 The New York Times states, “Pradaxa, which was approved in 2010, was the first in a new group of blood thinners intended to replace an older treatment, warfarin, which required patients to submit to frequent blood tests and adhere to a strict...

2014-06-10 23:03:31

The GlaxoSmithKline settlement involves the District of Columbia and 44 states over the marketing of Advair, Paxil, and Wellbutrin. Port Washington, NY (PRWEB) June 10, 2014 Parker Waichman LLP, a national law firm representing the victims of defective drugs is commenting on a recent settlement by drug maker, GlaxoSmithKline, over allegations involving the way in which Advair, Paxil, and Wellbutrin were marketed and how the drugs were promoted for off-label uses. According to a The...

2014-06-10 16:27:52

LONDON, June 10, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Antibody Partnering Terms and Agreementshttp://www.reportbuyer.com/countries/north_america/usa/antibody_partnering_terms_agreements.html The Antibody Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the antibody partnering deals and agreements entered into by the worlds leading healthcare companies.The Antibody Partnering Terms and...


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.